Molecular Docking and Structure-Based Drug Design Strategies
Tóm tắt
Pharmaceutical research has successfully incorporated a wealth of molecular modeling methods, within a variety of drug discovery programs, to study complex biological and chemical systems. The integration of computational and experimental strategies has been of great value in the identification and development of novel promising compounds. Broadly used in modern drug design, molecular docking methods explore the ligand conformations adopted within the binding sites of macromolecular targets. This approach also estimates the ligand-receptor binding free energy by evaluating critical phenomena involved in the intermolecular recognition process. Today, as a variety of docking algorithms are available, an understanding of the advantages and limitations of each method is of fundamental importance in the development of effective strategies and the generation of relevant results. The purpose of this review is to examine current molecular docking strategies used in drug discovery and medicinal chemistry, exploring the advances in the field and the role played by the integration of structure- and ligand-based methods.
Từ khóa
Tài liệu tham khảo
Hughes, 2011, Principles of early drug discovery, Br. J. Pharmacol., 162, 1239, 10.1111/j.1476-5381.2010.01127.x
Lipinski, 2012, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv. Drug Deliv. Rev., 64, 4, 10.1016/j.addr.2012.09.019
Weigelt, 2010, Structural genomics-Impact on biomedicine and drug discovery, Exp. Cell Res., 316, 1332, 10.1016/j.yexcr.2010.02.041
Salum, 2008, Structure-based approach for the study of estrogen receptor binding affinity and subtype selectivity, J. Chem. Inf. Model., 48, 2243, 10.1021/ci8002182
Kalyaanamoorthy, 2011, Structure-based drug design to augment hit discovery, Drug Discov. Today, 16, 831, 10.1016/j.drudis.2011.07.006
Acharya, 2011, Recent advances in ligand-based drug design: Relevance and utility of the conformationally sampled pharmacophore approach, Curr. Comput. Aided Drug Des., 7, 10, 10.2174/157340911793743547
Bacilieri, 2006, Ligand-based drug design methodologies in drug discovery process an overview, Curr. Drug Discov. Technol., 3, 155, 10.2174/157016306780136781
Drwal, 2013, Combination of ligand-and structure-based methods in virtual screening, Drug Discov. Today Technol., 10, e395, 10.1016/j.ddtec.2013.02.002
Trossini, 2013, Quantitative structure-activity relationships for a series of inhibitors of cruzain from Trypanosoma cruzi: Molecular modeling, CoMFA and CoMSIA studies, J. Mol. Graph. Model., 28, 3, 10.1016/j.jmgm.2009.03.001
Valasani, 2014, Structure based design, synthesis, pharmacophore modeling, virtual screening, and molecular docking studies for identification of novel cyclophilin D inhibitors, J. Chem. Inf. Mod., 54, 902, 10.1021/ci5000196
Blaney, 2012, A very short history of structure-based design: How did we get here and where do we need to go?, J. Comput. Aided Mol. Des., 26, 13, 10.1007/s10822-011-9518-x
Urwyler, 2011, Allosteric modulation of family C G-protein-coupled receptors: From molecular insights to therapeutic perspectives, Pharmacol. Rev., 63, 59, 10.1124/pr.109.002501
Wilson, 2011, Integrating structure-based and ligand-based approaches for computational drug design, Future Med. Chem., 3, 735, 10.4155/fmc.11.18
Fang, 2012, Ligand-receptor interaction platforms and their applications for drug discovery, Expert Opin. Drug Discov., 7, 969, 10.1517/17460441.2012.715631
Kahsai, 2011, Multiple ligand-specific conformations of the β2-adrenergic receptor, Nat. Chem. Biol., 7, 692, 10.1038/nchembio.634
Shoichet, 2012, Structure-based drug screening for G-protein-coupled receptors, Trends Pharmacol. Sci., 33, 268, 10.1016/j.tips.2012.03.007
Chandrika, 2009, Managing protein flexibility in docking and its applications, Drug Discov. Today, 14, 394, 10.1016/j.drudis.2009.01.003
Durrant, 2010, Computer-aided drug-discovery techniques that account for receptor flexibility, Curr. Opin. Pharmacol., 10, 770, 10.1016/j.coph.2010.09.001
Meng, 2011, Molecular docking: A powerful approach for structure-based drug discovery, Curr. Comput. Aided Drug Des., 7, 146, 10.2174/157340911795677602
Caulfield, 2011, Integrating virtual screening and combinatorial chemistry for accelerated drug discovery, Comb. Chem. High Throughput Screen., 14, 475, 10.2174/138620711795767866
Huang, 2010, Advances and challenges in protein-ligand docking, Int. J. Mol. Sci., 11, 3016, 10.3390/ijms11083016
Kapetanovic, 2008, Computer-aided drug discovery and development (CADDD): In silico-chemico-biological approach, Chem. Biol. Interact., 171, 165, 10.1016/j.cbi.2006.12.006
Yuriev, 2011, Challenges and advances in computational docking: 2009 in review, J. Mol. Recognit., 24, 149, 10.1002/jmr.1077
Agrafiotis, 2007, Conformational sampling of bioactive molecules: A comparative study, J. Chem. Inf. Model., 47, 1067, 10.1021/ci6005454
Sousa, 2006, Protein-ligand docking: Current status and future challenges, Proteins Struct. Funct. Bioinform., 65, 15, 10.1002/prot.21082
Zsoldos, 2007, eHiTS: A new fast, exhaustive flexible ligand docking system, J. Mol. Graph. Model., 26, 198, 10.1016/j.jmgm.2006.06.002
Gorelik, 2008, High quality binding modes in docking ligands to proteins, Proteins Struct. Funct. Bioinform., 71, 1373, 10.1002/prot.21847
McGann, 2012, FRED and HYBRID docking performance on standardized datasets, J. Comput. Aided Mol. Des., 26, 897, 10.1007/s10822-012-9584-8
Jain, 2003, Surflex: Fully automatic flexible molecular docking using a molecular similarity-based search engine, J. Med. Chem., 46, 499, 10.1021/jm020406h
Ewing, 2001, DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases, J. Comput. Aided Mol. Des., 15, 411, 10.1023/A:1011115820450
Morris, 1996, Distributed automated docking of flexible ligands to proteins: Parallel applications of AutoDock 2.4, J. Comput. Aided Mol. Des., 10, 293, 10.1007/BF00124499
Jones, 1997, Development and validation of a genetic algorithm for flexible docking, J. Mol. Biol., 267, 727, 10.1006/jmbi.1996.0897
Krovat, 2005, Recent advances in docking and scoring, Curr. Comput. Aided Drug Des., 1, 93, 10.2174/1573409052952314
Friesner, 2004, Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy, J. Med. Chem., 47, 1739, 10.1021/jm0306430
Pang, 2001, EUDOC: A computer program for identification of drug interaction sites in macromolecules and drug leads from chemical databases, J. Comput. Chem., 22, 1750, 10.1002/jcc.1129
Rarey, 1996, A fast flexible docking method using an incremental construction algorithm, J. Mol. Biol., 261, 470, 10.1006/jmbi.1996.0477
Welch, 1996, Hammerhead: Fast, fully automated docking of flexible ligands to protein binding sites, Chem. Biol., 3, 449, 10.1016/S1074-5521(96)90093-9
Miller, 1994, FLOG: A system to select “quasi-flexible” ligands complementary to a receptor of known three-dimensional structure, J. Comput. Aided Mol. Des., 8, 153, 10.1007/BF00119865
Schnecke, 1999, Database screening for HIV protease ligands: The influence of binding-site conformation and representation on ligand selectivity, Proc. Int. Conf. Intell. Syst. Mol. Biol., 242, 242
Mizutani, 1994, Rational automatic search method for stable docking models of protein and ligand, J. Mol. Biol., 243, 310, 10.1006/jmbi.1994.1656
Baxter, 1998, Flexible docking using Tabu search and an empirical estimate of binding affinity, Proteins, 33, 367, 10.1002/(SICI)1097-0134(19981115)33:3<367::AID-PROT6>3.0.CO;2-W
Grosdidier, 2007, EADock: Docking of small molecules into protein active sites with a multiobjective evolutionary optimization, Proteins, 67, 1010, 10.1002/prot.21367
Abagyan, 1994, ICM—A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation, J. Comput. Chem., 15, 488, 10.1002/jcc.540150503
Venkatachalam, 2003, LigandFit: A novel method for the shape-directed rapid docking of ligands to protein active sites, J. Mol. Graph. Model., 21, 289, 10.1016/S1093-3263(02)00164-X
Sochacka, 2014, Docking of thiopurine derivatives to human serum albumin and binding site analysis with Molegro Virtual Docker, Acta Pol. Pharm., 71, 343
Wu, 2003, Detailed analysis of grid-based molecular docking: A case study of CDOCKER-A CHARMm-based MD docking algorithm, J. Comput. Chem., 24, 1549, 10.1002/jcc.10306
Tietze, 2007, GlamDock: Development and validation of a new docking tool on several thousand protein-ligand complexes, J. Chem. Inf. Model., 47, 1657, 10.1021/ci7001236
Korb, 2009, Empirical scoring functions for advanced protein-ligand docking with PLANTS, J. Chem. Inf. Model., 49, 84, 10.1021/ci800298z
Thomsen, 2006, MolDock: A new technique for high-accuracy molecular docking, J. Med. Chem., 49, 3315, 10.1021/jm051197e
Corbeil, 2012, Variability in docking success rates due to dataset preparation, J. Comput. Aided Mol. Des., 26, 775, 10.1007/s10822-012-9570-1
Foloppe, 2006, Towards predictive ligand design with free-energy based computational methods?, Curr. Med. Chem., 13, 3583, 10.2174/092986706779026165
Jain, 2006, Scoring functions for protein-ligand docking, Curr. Protein Pept. Sci., 7, 407, 10.2174/138920306778559395
Huang, 2010, Scoring functions and their evaluation methods for protein-ligand docking: Recent advances and future directions, Phys. Chem. Chem. Phys., 12, 12899, 10.1039/c0cp00151a
Englebienne, 2009, Docking ligands into flexible and solvated macromolecules. 5. Force-field-based prediction of binding affinities of ligands to proteins, J. Chem. Inf. Model., 49, 2564, 10.1021/ci900251k
Kitchen, 2004, Docking and scoring in virtual screening for drug discovery: Methods and applications, Nat. Rev. Drug Discov., 3, 935, 10.1038/nrd1549
Murray, 1998, Empirical scoring functions. II. The testing of an empirical scoring function for the prediction of ligand-receptor binding affinities and the use of Bayesian regression to improve the quality of the model, J. Comput. Aided Mol. Des., 12, 503, 10.1023/A:1008040323669
Eldridge, 1997, Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes, J. Comput. Aided Mol. Des., 11, 425, 10.1023/A:1007996124545
Huang, 2006, An iterative knowledge-based scoring function to predict protein-ligand interactions: I. Derivation of interaction potentials, J. Comput. Chem., 27, 1866, 10.1002/jcc.20504
Gohlke, 2000, Knowledge-based scoring function to predict protein-ligand interactions, J. Mol. Biol., 295, 337, 10.1006/jmbi.1999.3371
Charifson, 1999, Consensus scoring: A method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins, J. Med. Chem., 42, 5100, 10.1021/jm990352k
Feher, 2006, Consensus scoring for protein-ligand interactions, Drug Discov. Today, 11, 421, 10.1016/j.drudis.2006.03.009
Terp, 2001, A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities, J. Med. Chem., 44, 2333, 10.1021/jm001090l
Wang, 2002, Further development and validation of empirical scoring functions for structure-based binding affinity prediction, J. Comput. Aided Mol. Des., 16, 11, 10.1023/A:1016357811882
Betzi, 2006, GFscore: A general nonlinear consensus scoring function for high-throughput docking, J. Chem. Inf. Model., 46, 1704, 10.1021/ci0600758
Teramoto, 2007, Supervised consensus scoring for docking and virtual screening, J. Chem. Inf. Model., 47, 526, 10.1021/ci6004993
Aharon, 2009, SeleX-CS: A new consensus scoring algorithm for hit discovery and lead optimization, J. Chem. Inf. Model., 49, 623, 10.1021/ci800335j
Okamoto, 2010, Evaluation of docking calculations on X-ray structures using CONSENSUS-DOCK, Chem. Pharm. Bull. Tokyo, 58, 1655, 10.1248/cpb.58.1655
Mysinger, 2010, Rapid context-dependent ligand desolvation in molecular docking, J. Chem. Inf. Model., 50, 1561, 10.1021/ci100214a
Ruvinsky, 2007, Role of binding entropy in the refinement of protein-ligand docking predictions: Analysis based on the use of 11 scoring functions, J. Comput. Chem., 28, 1364, 10.1002/jcc.20580
Wang, 2003, Comparative evaluation of 11 scoring functions for molecular docking, J. Med. Chem., 46, 2287, 10.1021/jm0203783
Yin, 2008, MedusaScore: An accurate force field-based scoring function for virtual drug screening, J. Chem. Inf. Model., 48, 1656, 10.1021/ci8001167
Rognan, 1999, Predicting binding affinities of protein ligands from three-dimensional models: Application to peptide binding to class I major histocompatibility proteins, J. Med. Chem., 42, 4650, 10.1021/jm9910775
Wang, 1998, SCORE: A new empirical method for estimating the binding affinity of a protein-ligand complex, Mol. Model. Annu., 4, 379, 10.1007/s008940050096
1994, The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure, J. Comput. Aided Mol. Des., 8, 243, 10.1007/BF00126743
Sotriffer, 2008, SFCscore: Scoring functions for affinity prediction of protein-ligand complexes, Proteins Struct. Funct. Bioinform., 73, 395, 10.1002/prot.22058
Reulecke, 2008, Towards an integrated description of hydrogen bonding and dehydration: Decreasing false positives in virtual screening with the HYDE scoring function, ChemMedChem, 3, 885, 10.1002/cmdc.200700319
Krammer, 2005, LigScore: A novel scoring function for predicting binding affinities, J. Mol. Graph. Model., 23, 395, 10.1016/j.jmgm.2004.11.007
Gehlhaar, 1995, Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: Conformationally flexible docking by evolutionary programming, Chem. Biol., 2, 317, 10.1016/1074-5521(95)90050-0
DeWitte, 1996, SMoG: De novo design method based on simple, fast, and accurate free energy estimates. 1. Methodology and supporting evidence, J. Am. Chem. Soc., 118, 11733, 10.1021/ja960751u
Muegge, 1999, Evaluation of PMF scoring in docking weak ligands to the FK506 binding protein, J. Med. Chem., 42, 2498, 10.1021/jm990073x
Xie, 2010, An interaction-motif-based scoring function for protein-ligand docking, BMC Bioinform., 11, 298, 10.1186/1471-2105-11-298
Ballester, 2010, A machine learning approach to predicting protein-ligand binding affinity with applications to molecular docking, Bioinformatics, 26, 1169, 10.1093/bioinformatics/btq112
Das, 2010, Binding affinity prediction with property-encoded shape distribution signatures, J. Chem. Inf. Model., 50, 298, 10.1021/ci9004139
Fan, 2011, Statistical potential for modeling and ranking of protein-ligand interactions, J. Chem. Inf. Model., 51, 3078, 10.1021/ci200377u
Kumalo, 2015, Theory and applications of covalent docking in drug discovery: Merits and pitfalls, Molecules, 20, 1984, 10.3390/molecules20021984
Ouyang, 2013, CovalentDock: Automated covalent docking with parameterized covalent linkage energy estimation and molecular geometry constraints, J. Comput. Chem., 34, 326, 10.1002/jcc.23136
Moitessier, 2008, Towards the development of universal, fast and highly accurate docking/scoring methods: A long way to go, Br. J. Pharmacol., 153, S7, 10.1038/sj.bjp.0707515
Xu, 2013, Induced fit docking, and the use of QM/MM methods in docking, Drug Discov. Today Technol., 10, e411, 10.1016/j.ddtec.2013.02.003
Menikarachchi, 2010, QM/MM approaches in medicinal chemistry research, Curr. Top. Med. Chem., 10, 46, 10.2174/156802610790232297
London, 2014, Covalent docking of large libraries for the discovery of chemical probes, Nat. Chem. Biol., 10, 1066, 10.1038/nchembio.1666
Bianco, G., Forli, S., Goodsell, D.S., and Olson, A.J. (2015). Covalent docking using Autodock: Two-point attractor and flexible sidechain methods. Protein Sci., Epub ahead of print.
Lin, 2011, Accommodating protein flexibility for structure-based drug design, Curr. Top. Med. Chem., 11, 171, 10.2174/156802611794863580
Salsbury, 2010, Molecular dynamics simulations of protein dynamics and their relevance to drug discovery, Curr. Opin. Pharmacol., 10, 738, 10.1016/j.coph.2010.09.016
Durrant, J.D., and McCammon, J.A. (2011). Molecular dynamics simulations and drug discovery. BMC Biol., 9.
Harvey, 2012, High-throughput molecular dynamics: The powerful new tool for drug discovery, Drug Discov. Today, 17, 1059, 10.1016/j.drudis.2012.03.017
Alonso, 2006, Combining docking and molecular dynamic simulations in drug design, Med. Res. Rev., 26, 531, 10.1002/med.20067
Nichols, 2011, Predictive power of molecular dynamics receptor structures in virtual screening, J. Chem. Inf. Model., 51, 1439, 10.1021/ci200117n
Cornell, 1995, A second generation force field for the simulation of proteins, nucleic acids, and organic molecules, J. Am. Chem. Soc., 117, 5179, 10.1021/ja00124a002
Brooks, 1983, CHARMM: A program for macromolecular energy, minimization, and dynamics calculations, J. Comp. Chem., 4, 187, 10.1002/jcc.540040211
Christen, 2005, The GROMOS software for biomolecular simulation: GROMOS05, J. Comput. Chem., 26, 1719, 10.1002/jcc.20303
Sousa, 2013, Protein-ligand docking in the new millennium—A retrospective of 10 years in the field, Curr. Med. Chem., 20, 2296, 10.2174/0929867311320180002
Klebe, 2006, Virtual ligand screening: Strategies, perspectives and limitations, Drug Discov. Today, 11, 580, 10.1016/j.drudis.2006.05.012
Bissantz, 2010, A medicinal chemist’s guide to molecular interactions, J. Med. Chem., 53, 5061, 10.1021/jm100112j
Michel, 2009, Energetics of displacing water molecules from protein binding sites: Consequences for ligand optimization, J. Am. Chem. Soc., 131, 15403, 10.1021/ja906058w
Amadasi, 2008, Robust classification of “relevant” water molecules in putative protein binding sites, J. Med. Chem., 51, 1063, 10.1021/jm701023h
Amadasi, 2006, Mapping the energetics of water-protein and water-ligand interactions with the “natural” HINT forcefield: Predictive tools for characterizing the roles of water in biomolecules, J. Mol. Biol., 358, 289, 10.1016/j.jmb.2006.01.053
Kellogg, 2004, The importance of being exhaustive. Optimization of bridging structural water molecules and water networks in models of biological systems, Chem. Biodivers., 1, 98, 10.1002/cbdv.200490016
Gonzalez, 2012, Chapter 4: Protein interactions and disease, PLoS Comput. Biol., 8, e1002819, 10.1371/journal.pcbi.1002819
Arkin, 2004, Small-molecule inhibitors of protein-protein interactions: Progressing towards the dream, Nat. Rev. Drug Discov., 3, 301, 10.1038/nrd1343
Wells, 2007, Reaching for high-hanging fruit in drug discovery at protein-protein interfaces, Nature, 450, 1001, 10.1038/nature06526
Sun, 2014, Discovery of AMG 232, a potent, selective, and orally bioavailable MDM2-p53 inhibitor in clinical development, J. Med. Chem., 57, 1454, 10.1021/jm401753e
Fuller, 2009, Predicting druggable binding sites at the protein-protein interface, Drug Discov. Today, 14, 155, 10.1016/j.drudis.2008.10.009
Laurie, 2005, Q-SiteFinder: An energy-based method for the prediction of protein-ligand binding sites, Bioinformatics, 21, 1908, 10.1093/bioinformatics/bti315
Meireles, 2010, ANCHOR: A web server and database for analysis of protein-protein interaction binding pockets for drug discovery, Nucleic Acids Res., 38, W407, 10.1093/nar/gkq502
Camacho, 2005, FastContact: Rapid estimate of contact and binding free energies, Bioinformatics, 21, 2534, 10.1093/bioinformatics/bti322
Moreira, 2010, Protein-protein docking dealing with the unknown, J. Comput. Chem., 31, 317, 10.1002/jcc.21276
Dominguez, 2003, HADDOCK: A protein-protein docking approach based on biochemical or biophysical information, J. Am. Chem. Soc., 125, 1731, 10.1021/ja026939x
Lyne, 2002, Structure-based virtual screening an overview, Drug Discov. Today, 7, 649, 10.1016/S1359-6446(02)02483-2
Stahura, 2004, Virtual screening methods that complement HTS, Comb. Chem. High Throughput Screen., 7, 259, 10.2174/1386207043328706
Kodadek, 2011, The rise, fall and reinvention of combinatorial chemistry, Chem. Commun., 47, 9757, 10.1039/c1cc12102b
Oprea, 2004, Integrating virtual screening in lead discovery, Curr. Opin. Chem. Biol., 8, 349, 10.1016/j.cbpa.2004.06.008
Geppert, 2010, Current trends in ligand-based virtual screening: Molecular representations, data mining methods, new application areas, and performance evaluation, J. Chem. Inf. Model., 50, 205, 10.1021/ci900419k
Ripphausen, 2011, State-of-the-art in ligand-based virtual screening, Drug Discov. Today, 16, 372, 10.1016/j.drudis.2011.02.011
Sliwoski, 2013, Computational methods in drug discovery, Pharmacol. Rev., 66, 334, 10.1124/pr.112.007336
Inglese, 2006, Quantitative high-throughput screening: A titration-based approach that efficiently identifies biological activities in large chemical libraries, Proc. Natl. Acad. Sci. USA, 103, 11473, 10.1073/pnas.0604348103
Molinspiration Cheminformatics. Available online: http://www.molinspiration.com/.
Jarrahpour, 2012, Petra, Osiris and Molinspiration (POM) together as a successful support in drug design: Antibacterial activity and biopharmaceutical characterization of some azo Schiff bases, Med. Chem. Res., 21, 1984, 10.1007/s00044-011-9723-0
Organic Chemistry Portal. Available online: http://www.organic-chemistry.org/prog/peo/.
Molsoft. Available online: http://molsoft.com/.
Molecular Discovery. Available online: http://www.moldiscovery.com/software/moka/.
Milletti, 2007, New and original pKa prediction method using grid molecular interaction fields, J. Chem. Inf. Model., 47, 2172, 10.1021/ci700018y
Spitzer, 2010, One concept, three implementations of 3D pharmacophore-based virtual screening: Distinct coverage of chemical search space, J. Chem. Inf. Model., 50, 1241, 10.1021/ci100136b
Wolber, 2008, Molecule-pharmacophore superpositioning and pattern matching in computational drug design, Drug Discov. Today, 13, 23, 10.1016/j.drudis.2007.09.007
Pharmacophore and ligand-based design with Biovia Discovery Studio® datasheet. Available online: http://accelrys.com/products/datasheets/pharmacophore-modeling.pdf.
Jones, 1995, A genetic algorithm for flexible molecular overlay and pharmacophore elucidation, J. Comput. Aided Mol. Des., 9, 532, 10.1007/BF00124324
Certara. Available online: http://www.certara.com/.
Martin, 1993, A fast new approach to pharmacophore mapping and its application to dopaminergic and benzodiazepine agonists, J. Comput. Aided. Mol. Des., 7, 83, 10.1007/BF00141577
Richmond, 2006, GALAHAD: 1. Pharmacophore identification by hypermolecular alignment of ligands in 3D, J. Comput. Aided Mol. Des., 20, 567, 10.1007/s10822-006-9082-y
Wolber, 2004, LigandScout: 3-D Pharmacophores derived from protein-bound ligands and their use as virtual screening filters, J. Chem. Inf. Model., 45, 160, 10.1021/ci049885e
Inteligand. Available online: http://www.inteligand.com/.
Chemical Computing Group. Available online: https://www.chemcomp.com/.
Dixon, 2006, PHASE: A new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results, J. Comput. Aided Mol. Des., 20, 10, 10.1007/s10822-006-9087-6
Schrodinger. Available online: http://www.schrodinger.com/.
Cresset. Available online: http://www.cresset-group.com/.
Vinter, 1994, Extended electron distributions applied to the molecular mechanics of some intermolecular interactions, J. Comput. Aided Mol. Des., 8, 653, 10.1007/BF00124013
PharmaGist. Available online: http://bioinfo3d.cs.tau.ac.il/PharmaGist/.
Dror, 2008, PharmaGist: A webserver for ligand-based pharmacophore detection, Nucleic Acids Res., 36, W223, 10.1093/nar/gkn187
Weininger, 1989, ALADDIN: An integrated tool for computer-assisted molecular design and pharmacophore recognition from geometric, steric, and substructure searching of three-dimensional molecular structures, J. Comput. Aided Mol. Des., 3, 225, 10.1007/BF01533070
Hoffmann, 1998, RAPID: Randomized pharmacophore identification for drug design, Comp. Geom., 4, 263
1997, Strategies for the determination of pharmacophoric 3D database queries, J. Comput. Aided Mol. Des., 11, 39, 10.1023/A:1008019326401
Koehler, 1991, Synthetic and computer assisted analysis of the pharmacophore for agonists at benzodiazepine receptors, Life Sci., 49, 207, 10.1016/0024-3205(91)90005-V
Dolata, 1998, CLEW: The generation of pharmacophore hypotheses through machine learning, SAR QSAR Environ. Res., 9, 53, 10.1080/10629369808039149
Holliday, 1997, Using a genetic algorithm to identify common structural features in sets of ligands, J. Mol. Graph. Model., 15, 221, 10.1016/S1093-3263(97)00080-6
Handschuh, 1998, Superposition of three-dimensional chemical structures allowing for conformational flexibility by a hybrid method, J. Chem. Inf. Comput. Sci., 38, 220, 10.1021/ci970438r
Chen, 1999, Automated pharmacophore identification for large chemical data sets, J. Chem. Inf. Comput. Sci., 39, 887, 10.1021/ci990327n
Talele, 1999, Three-dimensional quantitative structure-activity relationships (QSAR) and receptor mapping of cytochrome P-45014αDM inhibiting azole antifungal agents, J. Chem. Inf. Comput. Sci., 39, 204, 10.1021/ci9800413
Wang, 2000, LigBuilder: A multi-purpose program for structure-based drug design, J. Mol. Model., 6, 498, 10.1007/s0089400060498
LigBuilder. Available online: ligbuilder.org.
Lionta, 2014, Structure-based virtual screening for drug discovery: Principles, applications and recent advances, Curr. Top. Med. Chem., 14, 1923, 10.2174/1568026614666140929124445
Gangwal, 2015, Structure based virtual screening to identify selective phosphodiesterase 4B inhibitors, J. Mol. Graph. Model., 57, 89, 10.1016/j.jmgm.2015.01.007
Scior, 2012, Recognizing pitfalls in virtual screening: A critical review, J. Chem. Inf. Model., 52, 867, 10.1021/ci200528d
Cavasotto, 2007, Ligand docking and structure-based virtual screening in drug discovery, Curr. Top. Med. Chem., 7, 1006, 10.2174/156802607780906753
Kirchmair, 2008, Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection—What can we learn from earlier mistakes?, J. Comput. Aided Mol. Des., 22, 213, 10.1007/s10822-007-9163-6
Jain, 2008, Recommendations for evaluation of computational methods, J. Comput. Aided Mol. Des., 22, 133, 10.1007/s10822-008-9196-5
2012, Freely accessible databases of commercial compounds for high- throughput virtual screenings, Curr. Top. Med. Chem., 12, 866, 10.2174/156802612800166710
Sastry, 2010, Large-scale systematic analysis of 2D fingerprint methods and parameters to improve virtual screening enrichments, J. Chem. Inf. Model., 50, 771, 10.1021/ci100062n
Irwin, 2012, ZINC: A free tool to discover chemistry for biology, J. Chem. Inf. Model., 52, 1757, 10.1021/ci3001277
ZINC. Available online: zinc.docking.org.
PubChem, Available online: pubchem.ncbi.nlm.nih.gov.
Li, 2010, PubChem as a public resource for drug discovery, Drug Discov. Today, 15, 1052, 10.1016/j.drudis.2010.10.003
ChemSpider. Available online: www.chemspider.com.
Pence, 2010, ChemSpider: An online chemical information resource, J. Chem. Educ., 87, 1123, 10.1021/ed100697w
ChEMBL. Available online: www.ebi.ac.uk/chembl.
Bento, 2014, The ChEMBL bioactivity database: An update, Nucleic Acids Res., 42, D1083, 10.1093/nar/gkt1031
Núcleo de Bioensaios Biossíntese e Ecofisiologia de Produtos Naturais. Available online: http://nubbe.iq.unesp.br/portal/.
Valli, 2013, Development of a natural products database from the biodiversity of Brazil, J. Nat. Prod., 76, 439, 10.1021/np3006875
ChemBank. Available online: chembank.broadinstitute.org.
Seiler, 2008, ChemBank: A small-molecule screening and cheminformatics resource database, Nucleic Acids Res., 36, D351, 10.1093/nar/gkm843
eMolecules. Available online: www.emolecules.com.
DrugBank. Available online: drugbank.ca.
Wishart, 2006, DrugBank: A comprehensive resource for in silico drug discovery and exploration, Nucleic Acids Res., 34, D668, 10.1093/nar/gkj067
The Binding Database. Available online: www.bindingdb.org/bind/index.jsp.
Liu, 2007, BindingDB: A web-accessible database of experimentally determined protein-ligand binding affinities, Nucleic Acids Res., 35, D198, 10.1093/nar/gkl999
Akdemir, 2011, Acetylcholine binding protein (AChBP) as template for hierarchical in silico screening procedures to identify structurally novel ligands for the nicotinic receptors, Bioorganic Med. Chem., 19, 6107, 10.1016/j.bmc.2011.08.028
Pettersen, 2004, UCSF Chimera—A visualization system for exploratory research and analysis, J. Comput. Chem., 25, 1605, 10.1002/jcc.20084
UCSF Chimera. Available online: http://www.cgl.ucsf.edu/chimera/.
Humphrey, 1996, VMD: Visual molecular dynamics, J. Mol. Graph., 14, 33, 10.1016/0263-7855(96)00018-5
VMD Visual Molecular Dynamics. Available online: http://www.ks.uiuc.edu/Research/vmd.
Pymol. Available online: http://www.pymol.org/.
Lill, 2011, Computer-aided drug design platform using PyMOL, J. Comput. Aided Mol. Des., 25, 13, 10.1007/s10822-010-9395-8
Ball Biochemical Algorithms Library. Available online: http://www.ball-project.org/.
Moll, 2006, BALLView: A tool for research and education in molecular modeling, Bioinformatics, 22, 365, 10.1093/bioinformatics/bti818
Home Page for RasMol and OpenRasMol. Available online: http://www.rasmol.org/.
Sayle, 1995, RASMOL: Biomolecular graphics for all, Trends Biochem. Sci., 20, 374, 10.1016/S0968-0004(00)89080-5
Jmol: An open-source Java viewer for chemical structures in 3D. Available online: http://www.jmol.org/.
JSmol. Available online: http://wiki.jmol.org/index.php/JSmol.
Molle, 2010, Phosphorylation of InhA inhibits mycolic acid biosynthesis and growth of Mycobacterium tuberculosis, Mol. Microbiol., 78, 1591, 10.1111/j.1365-2958.2010.07446.x
Marrakchi, 2000, InhA, a target of the antituberculous drug isoniazid, is involved in a mycobacterial fatty acid elongation system, FAS-II, Microbiology, 146, 289, 10.1099/00221287-146-2-289
Pauli, 2013, Discovery of new inhibitors of Mycobacterium tuberculosis InhA enzyme using virtual screening and a 3D-pharmacophore-based approach, J. Chem. Inf. Model., 53, 2390, 10.1021/ci400202t
Abrahamian, 2003, Efficient generation, storage, and manipulation of fully flexible pharmacophore multiplets and their use in 3-D similarity searching, J. Chem. Inf. Comput. Sci., 43, 458, 10.1021/ci025595r
Adams, 2003, The proteasome: Structure, function, and role in the cell, Cancer Treat. Rev., 29, 3, 10.1016/S0305-7372(03)00081-1
Miller, 2015, Proteasome inhibitors with pyrazole scaffolds from structure-based virtual screening, J. Med. Chem., 58, 2036, 10.1021/jm501344n
Mitchell, 2005, Signal transducer and activator of transcription (STAT) signalling and T-cell lymphomas, Immunology, 114, 301, 10.1111/j.1365-2567.2005.02091.x
Timofeeva, 2013, STAT3 suppresses transcription of proapoptotic genes in cancer cells with the involvement of its N-terminal domain, Proc. Natl. Acad. Sci. USA, 110, 1267, 10.1073/pnas.1211805110
Matsuno, 2010, Identification of a new series of STAT3 inhibitors by virtual screening, ACS Med. Chem. Lett., 1, 371, 10.1021/ml1000273
Bachmann, 2005, The serine/threonine kinase Pim-1, Int. J. Biochem. Cell Biol., 37, 726, 10.1016/j.biocel.2004.11.005
Carnero, 2013, Pim kinases in cancer: Diagnostic, prognostic and treatment opportunities, Biochem. Pharmacol., 85, 629, 10.1016/j.bcp.2012.09.018
Ren, 2011, Discovery of novel Pim-1 kinase inhibitors by a hierarchical multistage virtual screening approach based on SVM model, pharmacophore, and molecular docking, J. Chem. Inf. Model., 51, 1364, 10.1021/ci100464b
Brownlee, 2001, Biochemistry and molecular cell biology of diabetic complications, Nature, 414, 813, 10.1038/414813a
Srivastava, 2005, Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options, Endocr. Rev., 26, 380, 10.1210/er.2004-0028
Wang, 2013, Discovery of new selective human aldose reductase inhibitors through virtual screening multiple binding pocket conformations, J. Chem. Inf. Model., 53, 2409, 10.1021/ci400322j
Perrone, 2010, Selective COX-1 inhibition: A therapeutic target to be reconsidered, Curr. Med. Chem., 17, 3769, 10.2174/092986710793205408
Wang, 2014, Aggravation of Alzheimer’s disease due to the COX-2-mediated reciprocal regulation of IL-1β and Aβ between glial and neuron cells, Aging Cell, 13, 605, 10.1111/acel.12209
Abramov, 2004, Beta-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase, J. Neurosci., 24, 565, 10.1523/JNEUROSCI.4042-03.2004
Rogers, 2012, Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature, Cold Spring Harb. Perspect. Med., 2, a006346